Patients with different subtypes of metabolic syndrome experience varying prevalence rates of stroke and ischemic heart disease.
The Food and Drug Administration (FDA) has moved to restrict the sale of unapproved ingestible fluoride prescription drug products, stating that action will be taken against any company marketing the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback